edoc

Expression of a specific variant surface glycoprotein has a major impact on suramin sensitivity and endocytosis in Trypanosoma brucei

Wiedemar, Natalie and Zwyer, Michaela and Zoltner, Martin and Cal, Monica and Field, Mark C. and Mäser, Pascal. (2019) Expression of a specific variant surface glycoprotein has a major impact on suramin sensitivity and endocytosis in Trypanosoma brucei. FASEB bioAdvances, 1 (10). pp. 595-608.

[img] PDF - Published Version
Available under License CC BY (Attribution).

1054Kb

Official URL: https://edoc.unibas.ch/75824/

Downloads: Statistics Overview

Abstract

Suramin was introduced into the clinic a century ago and is still used to treat the first stage of acute human sleeping sickness. Due to its size and sixfold negative charge, uptake is mediated through endocytosis and the suramin receptor in trypanosomes is thought to be the invariant surface glycoprotein 75 (ISG75). Nevertheless, we recently identified a variant surface glycoprotein (VSG; Sur; ) that confers strong in vitro resistance to suramin in a; Trypanosoma brucei rhodesiense; line. In this study, we introduced; VSG; Sur; into the active bloodstream expression site of a; T. b. brucei; line. This caused suramin resistance and cross resistance to trypan blue. We quantified the endocytosis of different substrates by flow cytometry and showed that the expression of VSG; Sur; strongly impairs the uptake of low-density lipoprotein (LDL) and transferrin, both imported by receptor-mediated endocytosis. However, bulk endocytosis and endocytosis of the trypanolytic factor were not affected, and the; VSG; Sur; -expressors did not exhibit a growth phenotype in the absence of suramin. Knockdown of ISG75 was synergistic with; VSG; Sur; expression, indicating that these two proteins are mediating distinct suramin resistance pathways. In conclusion, VSG; Sur; causes suramin resistance in; T. brucei; bloodstream forms by decreasing specific, receptor-mediated endocytosis pathways.
Faculties and Departments:09 Associated Institutions > Swiss Tropical and Public Health Institute (Swiss TPH)
09 Associated Institutions > Swiss Tropical and Public Health Institute (Swiss TPH) > Department of Medical Parasitology and Infection Biology (MPI) > Parasite Chemotherapy (Mäser)
09 Associated Institutions > Swiss Tropical and Public Health Institute (Swiss TPH) > Department of Medical Parasitology and Infection Biology (MPI) > Tuberculosis Research (Gagneux)
UniBasel Contributors:Wiedemar, Natalie and Zwyer, Michaela and Cal, Monica and Mäser, Pascal
Item Type:Article, refereed
Article Subtype:Research Article
Publisher:Wiley
ISSN:2573-9832
Note:Publication type according to Uni Basel Research Database: Journal article
Language:English
Identification Number:
edoc DOI:
Last Modified:11 Mar 2020 08:16
Deposited On:11 Mar 2020 08:16

Repository Staff Only: item control page